XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss), Net of Income Tax
Retained Earnings
Common stock, issued, beginning balance (in shares) at Jun. 30, 2023   69,465,446        
Common stock, treasury, beginning balance (in shares) at Jun. 30, 2023     (10,522,411)      
Common stock, outstanding, beginning balance (in shares) at Jun. 30, 2023   58,943,035        
Stockholder's equity, beginning balance at Jun. 30, 2023 $ 1,917,159 $ 695 $ (292,413) $ 479,878 $ (6,610) $ 1,735,609
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 345,136         345,136
Other comprehensive income (loss) 3,546       3,546  
Purchase of treasury stock (in shares)     (2,267,610)      
Purchase of treasury stock (83,781)   $ (83,781)      
Stock-based compensation activity, issued (in shares)   568,077        
Stock-based compensation activity, treasury stock (in shares)     (164,073)      
Stock-based compensation activity, outstanding (in shares)   404,004        
Stock-based compensation activity 14,233 $ 5 $ (8,383) 22,611    
Common stock, issued, ending balance (in shares) at Mar. 31, 2024   70,033,523        
Common stock, treasury, ending balance (in shares) at Mar. 31, 2024     (12,954,094)      
Common stock, outstanding, ending balance (in shares) at Mar. 31, 2024   57,079,429        
Stockholder's equity, ending balance at Mar. 31, 2024 2,196,293 $ 700 $ (384,577) 502,489 (3,064) 2,080,745
Common stock, issued, beginning balance (in shares) at Dec. 31, 2023   69,828,709        
Common stock, treasury, beginning balance (in shares) at Dec. 31, 2023     (12,930,332)      
Common stock, outstanding, beginning balance (in shares) at Dec. 31, 2023   56,898,377        
Stockholder's equity, beginning balance at Dec. 31, 2023 2,078,224 $ 698 $ (381,848) 493,268 (3,919) 1,970,025
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 110,720         110,720
Other comprehensive income (loss) 855       855  
Purchase of treasury stock (in shares)     (12,101)      
Purchase of treasury stock (595)   $ (595)      
Stock-based compensation activity, issued (in shares)   204,814        
Stock-based compensation activity, treasury stock (in shares)     (11,661)      
Stock-based compensation activity, outstanding (in shares)   193,153        
Stock-based compensation activity 7,089 $ 2 $ (2,134) 9,221    
Common stock, issued, ending balance (in shares) at Mar. 31, 2024   70,033,523        
Common stock, treasury, ending balance (in shares) at Mar. 31, 2024     (12,954,094)      
Common stock, outstanding, ending balance (in shares) at Mar. 31, 2024   57,079,429        
Stockholder's equity, ending balance at Mar. 31, 2024 $ 2,196,293 $ 700 $ (384,577) 502,489 (3,064) 2,080,745
Common stock, issued, beginning balance (in shares) at Jun. 30, 2024 70,221,632 70,221,632        
Common stock, treasury, beginning balance (in shares) at Jun. 30, 2024 (13,327,067)   (13,327,067)      
Common stock, outstanding, beginning balance (in shares) at Jun. 30, 2024 56,894,565 56,894,565        
Stockholder's equity, beginning balance at Jun. 30, 2024 $ 2,290,596 $ 702 $ (403,489) 510,232 (2,466) 2,185,617
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 322,233         322,233
Other comprehensive income (loss) 3,579       3,579  
Purchase of treasury stock (in shares)     (434,327)      
Purchase of treasury stock (27,870)   $ (27,870)      
Stock-based compensation activity, issued (in shares)   592,005        
Stock-based compensation activity, treasury stock (in shares)     (186,719)      
Stock-based compensation activity, outstanding (in shares)   405,286        
Stock-based compensation activity $ 15,362 $ 6 $ (14,317) 29,673    
Common stock, issued, ending balance (in shares) at Mar. 31, 2025 70,813,637 70,813,637        
Common stock, treasury, ending balance (in shares) at Mar. 31, 2025 (13,948,113)   (13,948,113)      
Common stock, outstanding, ending balance (in shares) at Mar. 31, 2025 56,865,524 56,865,524        
Stockholder's equity, ending balance at Mar. 31, 2025 $ 2,603,900 $ 708 $ (445,676) 539,905 1,113 2,507,850
Common stock, issued, beginning balance (in shares) at Dec. 31, 2024   70,571,332        
Common stock, treasury, beginning balance (in shares) at Dec. 31, 2024     (13,473,700)      
Common stock, outstanding, beginning balance (in shares) at Dec. 31, 2024   57,097,632        
Stockholder's equity, beginning balance at Dec. 31, 2024 2,521,962 $ 706 $ (413,257) 528,862 3,007 2,402,644
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 105,206         105,206
Other comprehensive income (loss) (1,894)       (1,894)  
Purchase of treasury stock (in shares)     (434,327)      
Purchase of treasury stock (27,870)   $ (27,870)      
Stock-based compensation activity, issued (in shares)   242,305        
Stock-based compensation activity, treasury stock (in shares)     (40,086)      
Stock-based compensation activity, outstanding (in shares)   202,219        
Stock-based compensation activity $ 6,496 $ 2 $ (4,549) 11,043    
Common stock, issued, ending balance (in shares) at Mar. 31, 2025 70,813,637 70,813,637        
Common stock, treasury, ending balance (in shares) at Mar. 31, 2025 (13,948,113)   (13,948,113)      
Common stock, outstanding, ending balance (in shares) at Mar. 31, 2025 56,865,524 56,865,524        
Stockholder's equity, ending balance at Mar. 31, 2025 $ 2,603,900 $ 708 $ (445,676) $ 539,905 $ 1,113 $ 2,507,850